Reference Terms
from Wikipedia, the free encyclopedia

COX-2 inhibitor

COX-2 selective inhibitor is a form of Non-steroidal anti-inflammatory drug (NSAID) that directly targets COX-2, an enzyme responsible for inflammation and pain.

Selectivity for COX-2 reduces the risk of peptic ulceration, and is the main feature of celecoxib, rofecoxib and other members of this drug class.

Cox-2-selectivity does not seem to affect other side-effects of NSAIDs (most notably an increased risk of renal failure), and some results have aroused the suspicion that there might be an increase in the risk for heart attack, thrombosis and stroke by a relative increase in thromboxane.

Rofecoxib was taken off the market in 2004 because of these concerns.

Note:   The above text is excerpted from the Wikipedia article "COX-2 inhibitor", which has been released under the GNU Free Documentation License.
Related Stories

Health & Medicine News
May 22, 2017

Latest Headlines
updated 12:56 pm ET